These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1769471)

  • 1. [Paf-acether and digestive tract].
    Denizot Y; Chaussade S; Couturier D
    Gastroenterol Clin Biol; 1991; 15(11):817-22. PubMed ID: 1769471
    [No Abstract]   [Full Text] [Related]  

  • 2. [PAF and diseases].
    Oda M; Satouchi K; Saito K
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):363-70. PubMed ID: 2024019
    [No Abstract]   [Full Text] [Related]  

  • 3. PAF-acether (platelet-activating factor).
    Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():355-8. PubMed ID: 2526498
    [No Abstract]   [Full Text] [Related]  

  • 4. Paf-acether (platelet-activating factor).
    Benveniste J
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():11-8. PubMed ID: 3159192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fecal platelet-activating factor (PAF). A marker of digestive inflammatory disorders].
    Denizot Y; Chaussade S; Couturier D
    Presse Med; 1993 Oct; 22(33):1704-6. PubMed ID: 8278326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
    Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
    J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet activating factor as a mediator of lesions of the digestive system].
    Polonskiĭ VM
    Klin Med (Mosk); 1990 Aug; 68(8):27-31. PubMed ID: 2084366
    [No Abstract]   [Full Text] [Related]  

  • 8. Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells.
    Pirotzky E; Ninio E; Bidault J; Pfister A; Benveniste J
    Lab Invest; 1984 Nov; 51(5):567-72. PubMed ID: 6492758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F; Joseph D; Touqui L; Vargaftig BB
    Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet aggregation and PAF-acether. Pharmacologic interference].
    Vargaftig BB; Fouque F; Lefort J
    J Pharmacol; 1984; 15 Suppl 1():69-84. PubMed ID: 6374298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the characteristics of functional disorders of the small intestine in certain diseases of the digestive tract].
    Linevskiĭ IuV
    Ter Arkh; 1966 May; 38(5):78-83. PubMed ID: 5991935
    [No Abstract]   [Full Text] [Related]  

  • 12. [Presence paf-acether mediator of inflammation in stools of patients with inflammatory enterocolitis].
    Denizot Y; Chaussade S; Colombel JF; Benveniste J; Couturier D
    C R Acad Sci III; 1991; 312(7):329-33. PubMed ID: 1908742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of platelet-activating factor in the mammalian female reproductive tract.
    Tiemann U
    Reprod Domest Anim; 2008 Dec; 43(6):647-55. PubMed ID: 18363604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
    Ibbotson GC; Wallace JL
    J Lipid Mediat; 1989; 1(5):273-82. PubMed ID: 2519897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
    Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
    Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory characteristics of PAF-acether in the skin of experimental animals and man.
    Archer CB; Page CP; Paul W; Morley J; MacDonald DM
    Int J Tissue React; 1985; 7(5):363-5. PubMed ID: 3863807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology].
    Gateau O
    Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():51-2. PubMed ID: 3117010
    [No Abstract]   [Full Text] [Related]  

  • 19. [Physiological mechanisms of compensation of the enteral syndrome in certain diseases of the digestive organs].
    Zlatkina AR; Gal'perin IuM; Makievskaia SE; Bezzubik KV; Misautova AA
    Ter Arkh; 1978; 50(2):44-9. PubMed ID: 646857
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.